DEVICE · Unmapped registry intervention
Berodual Respimat
Find medicine records ·
Find other trials using this name
Clinical trial
Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.
NCT00267917
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
Berodual HFA-MDI
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Berodual RespimatDEVICE
Berodual HFA-MDIDEVICE
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00267917 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.